Artal Group S.A.
SEC CIK 1053906 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Dir, 10% | 1.54M | $74.22M | — | 4 | 2023-06-05 | 2026-02-02 |
| CAVA | CAVA GROUP, INC. | Dir, 10% | 17.51M | — | $959.91M | 2 | 2024-06-05 | 2024-08-26 |
| CBIO | CRESCENT BIOPHARMA, INC. | 10% | 8.29M | $711.0K | — | 1 | 2023-02-21 | 2023-02-21 |
| SRRK | Scholar Rock Holding Corp | 10% | 9.03M | $455.1K | $10.4K | 2 | 2023-01-05 | 2023-01-09 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-02-04 | 2026-02-02 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal Group S.A. | Dir, 10% | P - Purchase | $1.30 | +1.54M | 1.54M | New | +$2.00M |
| MI | 2026-02-04 | 2026-02-02 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal Group S.A. | Dir, 10% | A - Grant | $2.33 | +22.77M | 367.1K | New | +$52.98M |
| 2024-08-28 | 2024-08-26 | CAVA | CAVA GROUP, INC. | Artal Group S.A. | Dir, 10% | S - Sale | $116.36 | -6.00M | 17.51M | -26% | -$698.16M | |
| 2024-06-07 | 2024-06-05 | CAVA | CAVA GROUP, INC. | Artal Group S.A. | Dir, 10% | S - Sale | $87.25 | -3.00M | 23.51M | -11% | -$261.75M | |
| DI | 2024-05-14 | 2024-05-10 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal Group S.A. | Dir, 10% | M - OptEx | — | +57.55M | 136.18M | +73% | — |
| I | 2023-06-05 | 2023-06-05 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal Group S.A. | Dir, 10% | P - Purchase | $2.60 | +27.78M | 78.63M | +55% | +$72.22M |
| M | 2023-02-23 | 2023-02-21+ | CBIO | CRESCENT BIOPHARMA, INC. | Artal Group S.A. | 10% | P - Purchase | $1.78 | +400.0K | 8.29M | +5% | +$711.0K |
| 2023-01-11 | 2023-01-09 | SRRK | Scholar Rock Holding Corp | Artal Group S.A. | 10% | S - Sale | $9.48 | -1,094 | 9.03M | -0.0% | -$10.4K | |
| 2023-01-09 | 2023-01-05 | SRRK | Scholar Rock Holding Corp | Artal Group S.A. | 10% | P - Purchase | $9.33 | +48.8K | 9.03M | +0.5% | +$455.1K |
Purchase Sale Sale after option exercise All abbreviations